Conversely, in cancer, KLF9 has emerged as a tumor-suppressor by inhibiting NF-κB, repressing metastasis-associated genes like MMP9 through chromatin remodeling and direct interference with NF-κB transcriptional activity. The gene discussed is NFKB1; the disease is neoplasm.